Abstract: Background: Sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) is emerging as a potential biomarker and therapeutic target in myalgic encephalomyelitis (ME), a …
Read moreLibrary
We have over 6,900 research abstracts in our library, as well as articles, news items, and press releases. You can search the library by topic, keywords, author, or date. You can also search categories and tags.
Abstract: While post-infectious (PI-ME/CFS) and gradual onset (GO-ME/CFS) myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) manifest similar symptoms, it has long been …
Read moreAbstract: Background: Long-COVID refers to ongoing, relapsing, or new symptoms present 30 or more days after Severe Acute Respiratory Syndrome Coronavirus …
Read moreAbstract: Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-Acute Sequelae of COVID-19 (PASC) often have neurocognitive complaints that involve …
Read moreIntroduction: In a recent, high-profile study of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS), Walitt et al. (2024) assessed the performance …
Read moreAbstract: While there are many postulates for the etiology of post-viral chronic fatigue and other symptomatology, little is known. We …
Read moreAbstract: Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) entails low quality of life for patients and massive societal costs. There is …
Read moreAbstract: The 5th International Symposium on Regulatory Autoantibodies Targeting GPCR (RAB-GPCRs) advanced the understanding of the significant role played by …
Read moreAbstract: Background: There are no known curative treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and current therapeutic regimens often yield inconsistent …
Read moreIntroduction: Fatigue is a common complaint experienced by most of subjects during lifetime, which affects approximately 30–50% of general population …
Read more